16 filings
424B3
Inhibrx Biosciences, Inc.
14 Aug 24
Prospectus supplement
4:18pm
424B3
Inhibrx Biosciences, Inc.
13 Aug 24
Prospectus supplement
4:10pm
8-K
Inhibrx Biosciences, Inc.
13 Aug 24
Inhibrx Biosciences Reports Second Quarter 2024 Financial Results
4:09pm
10-Q
2024 Q2
Inhibrx Biosciences, Inc.
13 Aug 24
Quarterly report
4:03pm
EFFECT
Inhibrx Biosciences, Inc.
20 Jun 24
Notice of effectiveness
12:15am
424B3
ecieenjyqpnwom
18 Jun 24
Prospectus supplement
5:28pm
8-K
cfas6zg1 kskcwebub3i
17 Jun 24
INHIBRX Investor Presentation Innovation Driven Outcomes Focused
4:03pm
S-1
kb1bygt8q1sapfi5mp
11 Jun 24
IPO registration
5:11pm
S-8
5o1wpd h4z6holgl0
30 May 24
Registration of securities for employees
5:11pm
8-K
125zi cll2jq3bplz
30 May 24
Entry into a Material Definitive Agreement
4:11pm
8-K
n4oirp6rb
24 May 24
Regulation FD Disclosure
4:21pm
SEC STAFF ACTION
va6lqlxzjzdgion7xe9
24 May 24
SEC staff action: Order
4:00pm
CERT
slzziyr ucxyj
24 May 24
Certification of approval for exchange listing
1:34pm
10-12B/A
deq5lfgtci7n7gx5ufw
15 May 24
Registration of securities (amended)
7:01am
10-12B/A
72y04nem h9pdk3hb
8 May 24
Registration of securities (amended)
7:00am
10-12B
vqce pe5ak
25 Apr 24
Registration of securities
6:30am
- Prev
- 1
- Next